Gyroscope Therapeutics announced today that it launched the roadshow for its initial public offering of nearly 7 million shares.
London-based Gyroscope’s U.S. offering includes up to 6.75 million American Depository Shares (ADSs) representing 6.75 million ordinary shares, according to a news release.
Get the full story at our sister site, Drug Delivery Business News.